Novel Phenylene Lipids That Are Positive Allosteric Modulators of Glycine Receptors and Inhibitors of Glycine Transporter 2
- PMID: 37466545
- DOI: 10.1021/acschemneuro.3c00167
Novel Phenylene Lipids That Are Positive Allosteric Modulators of Glycine Receptors and Inhibitors of Glycine Transporter 2
Abstract
Chronic pain is a complex condition that remains resistant to current therapeutics. We previously synthesized a series of N-acyl amino acids (NAAAs) that inhibit the glycine transporter, GlyT2, some of which are also positive allosteric modulators of glycine receptors (GlyRs). In this study, we have synthesized a library of NAAAs that contain a phenylene ring within the acyl tail with the objective of improving efficacy at both GlyT2 and GlyRs and also identifying compounds that are efficacious as dual-acting modulators to enhance glycine neurotransmission. The most efficacious positive allosteric modulator of GlyRs was 2-[8-(2-octylphenyl)octanoylamino]acetic acid (8-8 OPGly) which potentiates the EC5 for glycine activation of GlyRα1 by 1500% with an EC50 of 664 nM. Phenylene-containing NAAAs with a lysine headgroup were the most potent inhibitors of GlyT2 with (2S)-6-amino-2-[8-(3-octylphenyl)octanoylamino]hexanoic acid (8-8 MPLys) inhibiting GlyT2 with an IC50 of 32 nM. The optimal modulator across both proteins was (2S)-6-amino-2-[8-(2-octylphenyl)octanoylamino]hexanoic acid (8-8 OPLys), which inhibits GlyT2 with an IC50 of 192 nM and potentiates GlyRs by up to 335% at 1 μM. When tested in a dual GlyT2/GlyRα1 expression system, 8-8 OPLys caused the greatest reductions in the EC50 for glycine. This suggests that the synergistic effects of a dual-acting modulator cause greater enhancements in glycinergic activity compared to single-target modulators and may provide an alternate approach to the development of new non-opioid analgesics for the treatment of chronic pain.
Keywords: analgesics; dual action; glycine; glycine receptor; glycine transporter; lipids.
Similar articles
-
A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors.Biomolecules. 2020 Nov 30;10(12):1618. doi: 10.3390/biom10121618. Biomolecules. 2020. PMID: 33266066 Free PMC article.
-
Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.ACS Chem Neurosci. 2017 Sep 20;8(9):1949-1959. doi: 10.1021/acschemneuro.7b00105. Epub 2017 Jun 15. ACS Chem Neurosci. 2017. PMID: 28574249
-
Modulation of Glycinergic Neurotransmission may Contribute to the Analgesic Effects of Propacetamol.Biomolecules. 2021 Mar 25;11(4):493. doi: 10.3390/biom11040493. Biomolecules. 2021. PMID: 33805979 Free PMC article.
-
Glycine transport inhibitors for the treatment of pain.Trends Pharmacol Sci. 2014 Aug;35(8):423-30. doi: 10.1016/j.tips.2014.05.006. Epub 2014 Jun 21. Trends Pharmacol Sci. 2014. PMID: 24962068 Review.
-
Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.Neurochem Int. 2014 Jul;73:211-6. doi: 10.1016/j.neuint.2013.08.012. Epub 2013 Sep 12. Neurochem Int. 2014. PMID: 24036283 Review.
Cited by
-
Methods for negating the impact of zinc contamination to allow characterization of positive allosteric modulators of glycine receptors.Front Mol Neurosci. 2024 Jun 24;17:1392715. doi: 10.3389/fnmol.2024.1392715. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38979476 Free PMC article.
-
Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine-Glutamate Crosstalk.Biomedicines. 2024 Jul 8;12(7):1518. doi: 10.3390/biomedicines12071518. Biomedicines. 2024. PMID: 39062091 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical